 |
| ||||||
| |||||||
|
|
| ||||||
| |||||||
| ||||||
Indications for Use The AeroEclipse® II Breath Actuated Nebulizer ("BAN") is intended to be used by patients who are under the care or treatment of a licensed healthcare provider or physician. The device is intended to be used by these patients to administer aerosolized medication prescribed by a physician or healthcare professional. The intended environments for use include the home, hospitals and clinics. Features/Benefits The AeroEclipse® II BAN is a significant advance in small volume nebulization (SVN). Unlike continuous conventional nebulizers, it generates aerosol in response to the patient's inspiratory flow - patient-on-demand therapy. Patient-on-demand aerosol therapy means:
High output rate combined with over 78% respirable fraction translates into a very high respirable dose. This means shorter treatment times with the likelihood of better patient outcomes and reduced costs. The AeroEclipse® II BAN can be used in a continuous mode by turning the mode selector switch to the "continuous" position. |
|
|||||
|
|
||||||
|
||||||
|
||||||
child.jpg)
